Tuberculosis is a worldwide crisis, infecting nearly one third of the global population. Although TB is treatable with a strict, long-term and costly drug regimen, drug-resistant strains have emerged. Fortunately, University of Minnesota researchers have developed novel compounds believed to combat these strains, shorten the treatment time and make treatment less costly.
Courtney Aldrich, an associate professor with the Center for Drug Design, invented the potentially life-saving drug. The technology is currently undergoing pre-clinical studies.
The U of M has received a U.S. patent on the drug and the Office for Technology Commercialization is now seeking a commercialization partner.
September 29, 2011
Commercialization, Technology